Cargando…

Mediterranean diet: the impact on cardiovascular risk and metabolic syndrome in HIV patients, in Lisbon, Portugal

INTRODUCTION: Metabolic syndrome (MS) is common in HIV-infected individuals and it is associated with higher cardiovascular risk (CVR). Mediterranean diet has been associated with a better metabolic control and lower CVR. MATERIALS AND METHODS: From December 2013 to May 2014, individuals between 18...

Descripción completa

Detalles Bibliográficos
Autores principales:	Policarpo, Sara, Valadas, Emilia, Rodrigues, Teresa, Catarina Moreira, Ana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International AIDS Society 2014
Materias:	Poster Sessions – Abstract P195
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225313/ https://www.ncbi.nlm.nih.gov/pubmed/25397473 http://dx.doi.org/10.7448/IAS.17.4.19727

Ejemplares similares

Syndrome de Guillain-Barré post-COVID-19 traité par échanges plasmatiques
por: Khemekhem, Ameni, et al.
Publicado: (2021)

Hypovitaminosis D in HIV-infected patients in Lisbon: a link with antiretroviral treatment
por: Boura, Márcia, et al.
Publicado: (2014)

Effect of different cooking methods on the content of total vitamin C, ascorbic acid and dehydroascorbic acid of the galega kale
por: Vieira, Carolina, et al.
Publicado: (2021)

Causes of virological failure in a population of 1895 HIV-infected patients: the experience of an infectious diseases service in Lisbon, Portugal
por: Moneti, V, et al.
Publicado: (2012)

OTITE NECROTIZANTE COM MASTOIDITE POR ASPERGILLUS EM PACIENTE PÓS-COVID 19: UM RELATO DE CASO
por: Campos, Carolina Monteiro, et al.
Publicado: (2022)

Acceptability of PrEP among HIV negative Portuguese men who have sex with men that attended 2014 Lisbon pride fair
por: Miguel Rocha, Luís, et al.
Publicado: (2014)

Characteristics of late presentation of HIV infection in MSM and heterosexual adults in Portugal 2011–2013
por: Shivaji, Tara, et al.
Publicado: (2014)

Tackling cardiovascular co-morbidities in HIV-positive patients: who, how and where?
por: Rolls, Sophie, et al.
Publicado: (2014)

Cardiovascular markers of inflammation and serum lipid levels in HIV-infected patients with undetectable viraemia
por: Viskovic, Klaudija, et al.
Publicado: (2014)

Rates of cardiovascular events and deaths are associated with advanced stages of HIV-infection: results of the HIV HEART study 7, 5 year follow-up
por: Esser, Stefan, et al.
Publicado: (2014)

The potential impact of new national guidance on primary prevention of cardiovascular disease in people living with HIV
por: Ahmed, Nadia, et al.
Publicado: (2014)

Effect of hyperbilirubinaemia on neurocognitive, renal, bone and cardiovascular markers in HIV infection treated with boosted protease inhibitors
por: Barber, Tristan J, et al.
Publicado: (2014)

The efficacy, pharmacokinetics, safety and cardiovascular risks of switching nevirapine to rilpivirine in HIV-1 patients: the RPV switch study
por: Rokx, Casper, et al.
Publicado: (2014)

Effectiveness of a team intervention in reducing modifiable cardiovascular disease risk in HIV-infected subjects on antiretroviral therapy
por: Bloch, Mark, et al.
Publicado: (2014)

Monitoring of the lactonase activity of paraoxonase-1 enzyme in HIV-1-infection
por: Dias, Clara, et al.
Publicado: (2014)

Impact of NRTI backbone on renal, bone and cardiovascular markers in HIV-infected individuals receiving a boosted protease inhibitor
por: Barber, Tristan, et al.
Publicado: (2014)

Prevalence and concordance of high cardiovascular disease scores in HIV/AIDS patients from Croatia and Serbia with four international algorithms
por: Begovac, Josip, et al.
Publicado: (2014)

Evolution of Framingham cardiovascular risk score in HIV-infected patients initiating EFV- and LPV/r-based HAART in a Latin American cohort
por: Cecchini, Diego, et al.
Publicado: (2014)

Evolution trends over three decades of HIV infection late diagnosis: the experience of a Portuguese cohort of 705 HIV-infected patients
por: Claudia Miranda, Ana, et al.
Publicado: (2014)

Viro-immunological characterization of naïve patients with high cerebrospinal fluid (CSF) HIV RNA
por: Iannuzzi, Francesca, et al.
Publicado: (2014)

Analysis of hepatitis non-treatment causes in a cohort of HCV and HCV/HIV infected patients
por: Pereira, Karen, et al.
Publicado: (2014)

Determinants of HIV outpatient service utilization according to HIV parameters
por: Di Carlo, Paola, et al.
Publicado: (2014)

Transmission route and reasons for HIV testing among recently diagnosed HIV patients in HIV-TR cohort, 2011–2012
por: Dokuzoguz, Basak, et al.
Publicado: (2014)

Universal Tre (uTre) recombinase specifically targets the majority of HIV-1 isolates
por: Karpinski, Janet, et al.
Publicado: (2014)

Durability of first antiretroviral treatment in HIV chronically infected patients: why change and what are the outcomes?
por: Moniz, Patricia, et al.
Publicado: (2014)

Lamivudine plus darunavir boosted with ritonavir as simplification dual regimen in HIV-infected patients
por: Luis Casado, Jose, et al.
Publicado: (2014)

Loss to follow-up of HIV-infected women after delivery: The Swiss HIV Cohort Study and the Swiss Mother and Child HIV Cohort Study
por: Aebi-Popp, Karoline, et al.
Publicado: (2014)

Efficacy, safety, and lack of interactions with the use of raltegravir in HIV-infected patients undergoing antineoplastic chemotherapy
por: Bañón, Sara, et al.
Publicado: (2014)

Switch to raltegravir-based regimens and HIV DNA decrease in patients with suppressed HIV RNA
por: Bianco, Claudia, et al.
Publicado: (2014)

Sex differences in apolipoprotein A1 and nevirapine-induced toxicity
por: Marinho, Aline, et al.
Publicado: (2014)

Effect of HIV infection-related factors on SVR rate in HCV treatment in HIV-infected patients
por: Kravchenko, Alexey, et al.
Publicado: (2014)

Cerebrospinal fluid biomarkers in patients with plasma HIV RNA below 20 copies/mL
por: Calcagno, Andrea, et al.
Publicado: (2014)

Association between abdominal aortic calcifications, bone mineral density and vertebral fractures in a cohort of HIV-positive patients
por: Iannotti, Nathalie, et al.
Publicado: (2014)

Safety of darunavir/ritonavir (DRV/r) in HIV-1-infected DRV/r-experienced and -naïve patients: analysis of data in the real-world setting in Italy
por: Antinori, Andrea, et al.
Publicado: (2014)

Improve screening of HCV infection by targeting high prevalence aged groups: analysis of a cohort of HCV and HIV co-infected patients
por: Brogueira, Pedro, et al.
Publicado: (2014)

A clinical and pharmacokinetic study of the combination of etravirine plus raltegravir in HIV patients with expanded intolerance or resistance
por: Bañón, Sara, et al.
Publicado: (2014)

Recreational drugs and HIV in Europe: current use of recreational drugs and principal HIV guidelines related recommendations
por: Garin Escriva, Noe, et al.
Publicado: (2014)

The suspected unexpected and serious adverse events of antiretroviral drugs used as HIV prophylaxis in HIV uninfected persons
por: Pietraszkiewicz, Ewa, et al.
Publicado: (2014)

Liver Fibrosis progression using Fibroscan in HIV/HCV coinfected patients with undetectable HIV viral load
por: Perez-Martinez, Laura, et al.
Publicado: (2014)

Risk of liver decompensation assessed in HIV/HCV co-infected individuals with advanced liver fibrosis: a faster countdown experience
por: Pedro Alves, Joao, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_u82kve1tb21qp8ud5mt5lk4le5